越南患有刺激性肠综合征患者的焦虑和抑郁障碍:一项跨部门临床研究
Trung Nam Phan1, Quoc Khanh Tran1, Xuan Long Truong1
1Gastroenterology and Endoscopy Center Hospital of University of Medicine and Pharmacy, Hue University Hue Vietnam.
JGH open : an open access journal of gastroenterology and hepatology
|February 17, 2025
概括
越南患者患有刺激性肠综合征 (IBS) 的焦虑和抑郁是常见的. 像IBS-M和IBS-D这样的IBS亚型,以及更多的胃肠道症状,与更高的心理痛苦相关,特别是在女性中.
科学领域:
- 胃肠病学 胃肠病学
- 精神病学是一个精神病学.
- 流行病学 流行病学
背景情况:
- 刺激性肠综合征 (IBS) 是一种常见的功能性胃肠疾病.
- 在IBS和心理疾病,如焦虑和抑郁症之间存在显著的联系.
- 这项研究调查了越南IBS患者中这些心理问题的患病率.
研究的目的:
- 通过使用"罗马四号标准"来确定被诊断患有IBS的越南患者焦虑和抑郁的患病率.
- 探索IBS亚型与焦虑和抑郁的存在之间的关联.
- 确定影响IBS患者抑郁症风险的人口因素.
主要方法:
- 一项涉及186名通过罗马四号标准诊断的IBS患者的横截面研究.
- 使用越南版本的医院焦虑和抑郁量表 (HADS) 评估了焦虑和抑郁.
- 进行了统计分析,以比较IBS亚型和人口统计数据中的心理痛苦.
主要成果:
- 可能的焦虑和抑郁 (HADS ≥11) 的患病率分别为21.0%和11.8%.
- 有意义的症状 (HADS ≥8) 表示更高的患病率:55.9%的焦虑和40.8%的抑郁.
- 患有IBS-M,IBS-D或IBS-C的患者表现出显著更高的抑郁症几率 (OR分别为6.585,7.013,4.261;p < 0.001).
- 与女性相比,男性患抑郁症的可能性较小.
结论:
- 越南IBS患者患有高频率的焦虑和抑郁症.
- IBS亚型,特别是IBS-M和IBS-D,以及较高的症状负担与增加的心理痛苦有关.
- 女性和患有特定IBS亚型的患者面临更大的抑郁和焦虑风险.
相关概念视频
01:17Irritable Bowel Syndrome I: Introduction
226
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
226
01:30Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
113
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
113
01:30Irritable Bowel Syndrome III: Medical and Nursing Management
144
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
144
01:17Chronic Bowel Disorders: Introduction
380
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
380
01:17Drugs for Treatment of Diarrhea-Predominant IBS
140
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
140
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
301
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
301